ZAI LAB (09688) plans to issue approximately 7.8431 million American Depositary Shares.

ZAI LAB (09688) announced, on November 13, 2024 (Eastern Time in the United States), the company filed a supplemental document to the SEC for the initial public offering. On November 14, 2024 (Eastern Time in the United States), the company entered into an underwriting agreement with underwriters, whereby the company agreed to issue and sell a total of 7,843,137 American Depositary Shares (representing 78,431,370 shares of related stock with a total face value of $470.59). Each American Depositary Share represents 10 shares of common stock of the company. The offering price per American Depositary Share is $25.50. The company also granted the underwriters a 30-day option to purchase an additional 1,176,470 American Depositary Shares (representing 11,764,700 shares of related stock with a total face value of $70.59) at a discount to the offering price minus underwriting discount and commissions. The announcement stated that the expected net proceeds from the offering are approximately $188 million to $216 million, intended for general corporate purposes.